Latest Global Growth Strategy News

WCM Global Growth reported a $66.7 million profit for FY2026, slightly down from last year, but boosted its final dividend and outlined a progressive dividend increase plan while completing a major $84.8 million capital raising.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.

WCM Global Growth Limited has raised its fully franked quarterly dividend to 2.21 cents per share for Q3 FY2026, signaling a progressive dividend policy with planned increases through to March 2027, backed by strong long-term portfolio performance.

HyTerra Limited has partnered with Omani operator ARA Natural Resources to explore geologic hydrogen opportunities in Oman’s Semail Ophiolite, aiming to pioneer commercialisation in a promising low-carbon energy frontier.

WCM Global Growth Limited has raised approximately $85 million through a share placement and entitlement offer priced at $1.75 per share, aiming to strengthen its global growth investment strategy and enhance shareholder value.

RLF AgTech has secured strategic distribution partnerships with two leading Indian agricultural groups, marking its commercial entry into one of the world’s largest crop nutrition markets. These agreements position RLF for rapid expansion in India’s vast and growing agricultural sector.

WCM Global Growth Limited reported a net operating profit of $22.9 million for H1 FY2026 and announced an increased fully franked interim dividend, reinforcing its progressive dividend policy.

CurveBeam AI has received the first A$4 million tranche of a planned A$10 million strategic investment from a leading Chinese orthopaedic device company, marking a significant step in its expansion into the Chinese market.

Temas Resources has appointed Nic Matich as a Non-Executive Director to spearhead Australian investor relations and business development, while CFO David Robinson transitions to a full-time executive role to sharpen financial oversight amid the company’s growth and commercialisation push.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

Memphasys has inked a five-year supply agreement with Italy’s Centro Fertilita Assistita, marking its first major European contract and setting the stage for broader adoption of its Felix™ sperm isolation system.

RemSense Technologies has secured a follow-up contract with ExxonMobil to deliver advanced digital twin solutions at the Bass Strait facility, reinforcing its role in the energy sector’s digital transformation.